BiotechTube

ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Multiple Sclerosis

Conditions

Multiple Sclerosis

Trial Timeline

Mar 1, 2010 → Dec 1, 2011

NCT ID
NCT01081782

About ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placebo

ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placebo is a phase 2 stage product being developed by Ono Pharmaceutical for Multiple Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01081782. Target conditions include Multiple Sclerosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01081782Phase 2Completed

Competing Products

20 competing products in Multiple Sclerosis

See all competitors
ProductCompanyStageHype Score
Placebo + PirtobrutinibEli LillyPhase 2
52
Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomideEli LillyPhase 1/2
41
NEX-20ANanexa ABPhase 1
28
agenT-797MiNK TherapeuticsPhase 1
25
Duloxetine Hydrochloride (HCI) + PlaceboEli LillyPhase 3
77
TemferonGenenta SciencePhase 1/2
33
CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab)CelltrionPhase 3
77
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
CS-0777 tablets + CS-0777 tablets + CS-0777 tabletsDaiichi SankyoPhase 1
33
ASP7487, Velcade, DexamethasoneAstellas PharmaPhase 1/2
41
PHE885NovartisPhase 2
52
Mirabegron + PlaceboAstellas PharmaApproved
85
Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + PlaceboAstellas PharmaApproved
85
Denileukin Diftitox (Ontak)EisaiPhase 1
33
PalonosetronEisaiPhase 2
52
BIW-8962Kyowa KirinPhase 1
33
KRN125(pegfilgrastim), PLR001(plerixafor) + KRN8601(filgrastim), PLR001(plerixafor)Kyowa KirinPhase 2
52
KW-2478 + BortezomibKyowa KirinPhase 1/2
41
ONO-2808 + PlaceboOno PharmaceuticalPhase 2
52
KW-2478Kyowa KirinPhase 1
33

Other Products from Ono Pharmaceutical

Sivelestat sodium hydrate + Sivelestat sodium hydrateApproved
85
Abatacept + Placebo matching with Abatacept + MethotrexateApproved
85
Rivastigmine transdermal patchApproved
85
Sitagliptin phosphatePhase 3
77
ONO-4538 + Carboplatin + Paclitaxel + Bevacizumab + PlaceboPhase 3
77